Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research


National Glaucoma Research
Current Award

Dr. Kevin Chan

Kevin Chan, Ph.D.

University of Pittsburgh
Pittsburgh, PA

Title: Effects of Ocular Hypertension on Visual Brain Damage
Non-Technical Title: Effects of Prolonged Eye Pressure Elevation on Visual Brain Changes

Joel Schuman, M.D.,
University of Pittsburgh
Ian Conner, M.D., Ph.D.
University of Pittsburgh

Duration: July 1, 2013 - June 30, 2015
Award Type: Standard
Award Amount: $100,000


Glaucoma is the second leading cause of blindness in the world. Although elevated eye pressure is a major risk factor, recent evidence suggested the involvement of the visual brain, apart from the eye, in the early degenerative mechanisms of glaucoma. Drs. Chan, Conner and Schuman’s goal is to develop new structural, metabolic, and functional magnetic resonance imaging (MRI, a machine that takes detailed images of the inside of the body) techniques for glaucoma. They will make whole-brain, non-invasive and repeated measurements over a period of time to evaluate the damage to the visual pathway and disease progression under different levels of chronic high eye pressure, and monitor for potential neuroprotection after treatment with a drug that lowers eye pressure. The development of novel methods for characterizing chronic glaucoma and neuroprotection in the visual system can potentially lead to more timely intervention and targeted treatments in reducing the burden of this disease.


Although elevated eye pressure is a major risk factor for glaucoma, recent evidence suggests the involvement of the visual brain, apart from the eye, in the early degenerative mechanisms of glaucoma. Drs. Chan, Conner and Schuman’s laboratory is testing the hypothesis that the degenerative events that occur in the visual pathways in the brain under chronic ocular hypertension can be detected and quantified using [1] microstructural, [2] metabolic and [3] functional MRI at a high magnetic field strength. In addition, they will investigate the neuroprotective effects of a commonly used ocular hypotensive drug on the changes to the visual pathways under elevated eye pressure.

When the study is complete, this project will offer, for the first time, an ability to measure non-invasive and comprehensive indicators for longitudinally assessing the structural, metabolic and functional effects on the visual system in glaucoma. In addition, the information provided will help to understand the very core of the processes that result in visual brain damage after different levels of prolonged elevation of eye pressure in glaucoma. This knowledge may lead to more targeted treatments and improved visual outcomes for reducing the burden of the disease.

Drs. Chan, Conner and Schuman expect that the proposed imaging approaches will greatly enhance the ability to detect and predict glaucoma progression in the visual system, and therefore allow for interventions at the earliest possible stage. Furthermore, the imaging techniques developed in this project could be used in the future to assess the beneficial effects of treatments for chronic glaucoma and other eye diseases that involve the brain. The team is excited to be involved in this research effort, and appreciates the BrightFocus donors’ support of their glaucoma neuroimaging work.

Investigator Biography:

Dr. Chan is an Assistant Professor of Ophthalmology and Bioengineering at the University of Pittsburgh. He completed his doctoral studies at The University of Hong Kong and was awarded the Li Ka Shing Prize for the best PhD thesis at the University. Dr. Chan is directing an MRI research program on structural, metabolic and functional imaging of the visual system in health and disease. His laboratory focuses on developing new methods of non-invasively imaging neurodegeneration, neurodevelopment, neuroplasticity and neuroregeneration in eye diseases and injuries to provide better strategies for vision preservation and restoration. In addition to his BrightFocus award, Dr. Chan is a Junior Fellow of the International Society for Magnetic Resonance in Medicine and was a 2009-2010 Fulbright Scholar. He is currently a Deputy Editor of the Journal of Magnetic Resonance Imaging.